Israel-based Belkin Vision announced that it has received CE Mark for its Eagle device, making it the first automated, non-contact glaucoma laser treatment available within Europe.
Oertli's OS 4 platform is a powerful, multifaceted system designed for retinal, glaucoma, and cataract surgeries. At its core lies a 3-pump mechanism featuring vacuum and flow regulation, as well as a novel SPEEP pump.
Icare USA announced 510(k) clearance from the FDA for their next generation self-tonometer, the iCare HOME2.
Nova Eye Medical announced the launch of its next generation canaloplasty device, iTrack Advance, in select markets in Europe and the Asia Pacific.
According to GlobalData, the glaucoma market across the seven major markets* is predicted to grow steadily from $2.8 billion in 2020 to $3.5 billion in 2030, with a compound annual growth rate (CAGR) of 2%.